Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

66455 1511973626HCLSTunisiaNovember2017.pdf
Energy Boardroom

Luxembourg Pharma Report

January 2017

This report offers companies, investors, policymakers, and stakeholders crucial insight into Luxembourg; a country that is rapidly breaking away from its reputation as simply a tiny European tax haven and establishing itself as a serious regional and global healthcare and life sciences player. Luxembourg has prioritized personalized healthcare; e-health and data security; and pharma logistics and air freight as the three pillars of its healthcare strategy and is reaping the rewards.

The report features in-depth exclusive interviews with leading figures from public institutions and private companies, comprehensive articles, and up-to-date facts and figures on the Luxembourgish healthcare and pharma sectors.

want to know more?

contents

  • ACKNOWLEDGEMENTS
  • FOREWORDS
  • SNAPSHOT IN FIGURES
  • PREFACE
  • MINISTERIAL INSIGHT INTERVIEW Lydia Mutsch, Minister of Health
  • SOCIAL SECURITY SYSTEM INTERVIEW Romain Schneider, Minister of Social Security
  • PIONEERING PHARMA LEADER FEATURE An Emerging Global Player
  • PERSONALIZED HEALTHCARE INTERVIEW Dr. Catherine Larue, Luxembourg Institute of Health
  • BIOBANKING INTERVIEW Marc Vandelaer, Integrated Biobank of Luxembourg
  • RESEARCH AND DEVELOPMENT INTERVIEW Rudi Balling, Luxembourg Centre for Systems Biomedicine
  • BIG DATA FEATURE Cyber-security, Analytics, and Digital Literacy
  • INNOVATION INTERVIEW Jean-Paul Schuler & Thomas Dentzer, Luxinnovation
  • NATIONAL CANCER PLAN FEATURE The Fight Against Cancer
  • CLINICAL TRIALS INTERVIEW Reginald Decraene, Pfizer Luxembourg

COVER STORY

TIME TO BE TAKEN SERIOUSLY!

  1. The Great Re-Inventor
  2. A Strong Supporting Cast
  3. Getting the Fundamentals Right
  4. Research Pedigree & The Melting Pot of Ideas
  5. Facing Up to Limitations
  6. Importing the Very Best of Foreign Talent
  7. Standing Out from the Crowd
  8. A Great Place to Headquarter?
  9. The Responsible Partner
  10. Blazing Trails: Where Luxembourg Can Really Claim to Lead
  11. Virtues of a Microcosm
  12. Made in Luxembourg
  13. The Advent of Harmonized Drug Procurement and Pricing
  14. The Gold Standard of Public Health
  15. Growth Spots: Clinical Trials
  16. Lofty Ambitions
  • ACADEMIC INFRASTRUCTURE FEATURE Medical Education
  • RESEARCH INVESTMENT INTERVIEW Marc Schiltz, Luxembourg National Research Fund
  • DIGITALIZATION INTERVIEW Luc Brucher, Deloitte

featuring

  • Lydia Mutsch Minister of Health
  • Romain Schneider Minister of Social Security
  • Dr. Catherine Larue Luxembourg Institute of Health
  • Marc Vandelaer Integrated Biobank of Luxembourg
  • Rudi Balling Luxembourg Centre for Systems Biomedicine
  • Jean-Paul Schuler & Thomas Dentzer Luxinnovation
  • Reginald Decraene Pfizer
  • Marc Schiltz Luxembourg National Resarch Fund
  • Luc Brucher Deloitte

Most Read


X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: